Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-19

Clinical Trial Update: Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain

View source ↗

Summary

This document reports a clinical trial investigating cenobamate as an early add-on therapy for focal epilepsy across France, Germany, and Spain, currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cenobamate (cenobamate)

Snippet

Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A | Conditions: Focal Epilepsy With and Without Secondary Generalization | Status: RECRUITING